Alyssa Hohn

A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells

N. Swamy, A. Saguner, I. Akin, 2022, International journal of molecular sciences.

Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived cardiomyocytes and preclinical drug screening

A. Hierlemann, A. Saguner, I. Akin, 2021, Clinical and translational medicine.

Novel insights in the pathomechanism of Brugada syndrome and fever‐related type 1 ECG changes in a preclinical study using human‐induced pluripotent stem cell‐derived cardiomyocytes

I. Akin, I. El-Battrawy, L. Cyganek, 2023, Clinical and translational medicine.